Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis

Overview of attention for article published in Frontiers in endocrinology, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 57,474 followers.

RT @FrontEndocrinol: New Research: Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone los…

PHPT always a challenge to treat medically.

Medical treatment of primary #hyperparathyroidism remains a topic of debate. In this meta-analysis, we looked at antiresorptives- bisphosphonates and denosumab. Excellent work by colleagues from @CSIR_CDRI @iofbonehealth @ASBMR @IndiaESI @ISBMRTweets ht

RT @FrontEndocrinol: New Research: Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone los…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.